Gisa Ellrichmann

3.6k total citations · 1 hit paper
54 papers, 2.2k citations indexed

About

Gisa Ellrichmann is a scholar working on Neurology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gisa Ellrichmann has authored 54 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 16 papers in Pathology and Forensic Medicine and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gisa Ellrichmann's work include Multiple Sclerosis Research Studies (16 papers), Genetic Neurodegenerative Diseases (14 papers) and Peripheral Neuropathies and Disorders (10 papers). Gisa Ellrichmann is often cited by papers focused on Multiple Sclerosis Research Studies (16 papers), Genetic Neurodegenerative Diseases (14 papers) and Peripheral Neuropathies and Disorders (10 papers). Gisa Ellrichmann collaborates with scholars based in Germany, United States and Israel. Gisa Ellrichmann's co-authors include Ralf Gold, Ralf A. Linker, De-Hyung Lee, Stefan Wiese, Carsten Saft, Rebecca Conrad, Christiane Reick, Robert H. Scannevin, Susan Goelz and Pradeep Bista and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and SHILAP Revista de lepidopterología.

In The Last Decade

Gisa Ellrichmann

53 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

2011 892 citations Ralf A. Linker, De-Hyung Lee et al. profile →

Peers

Countries citing papers authored by Gisa Ellrichmann

Since Specialization

Citations

This map shows the geographic impact of Gisa Ellrichmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gisa Ellrichmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gisa Ellrichmann more than expected).

Fields of papers citing papers by Gisa Ellrichmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gisa Ellrichmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gisa Ellrichmann. The network helps show where Gisa Ellrichmann may publish in the future.

Co-authorship network of co-authors of Gisa Ellrichmann

This figure shows the co-authorship network connecting the top 25 collaborators of Gisa Ellrichmann. A scholar is included among the top collaborators of Gisa Ellrichmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gisa Ellrichmann. Gisa Ellrichmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence of Parkinson’s disease in Germany based on prevalence data from 70 million patients of the statutory health insurance 2024 ·BMC Neurology ·(unknown), Gisa Ellrichmann, Insa Feinkohl, (unknown), Ralph Brinks	2
2	Subarachnoid hemorrhages and aneurysms during the SARS-CoV2-pandemia at a tertiary medical center – Analysis of incidence and outcome 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Gisa Ellrichmann, (unknown), (unknown), Oliver Müller	2
3	Evidences for Mutant Huntingtin Inducing Musculoskeletal and Brain Growth Impairments via Disturbing Testosterone Biosynthesis in Male Huntington Disease Animals 2022 ·Cells ·Libo Yu-Taeger, Arianna Novati, Jonasz Jeremiasz Weber, (unknown), (unknown), Fubo Cheng, Carsten Saft, Jennifer Koenig, Gisa Ellrichmann, Taneli Heikkinen, Mahmoud A. Pouladi, Olaf Rieß, Huu Phuc Nguyen	4
4	Positive effect of immunomodulatory therapies on disease progression in Huntington’s disease? Data from a real-world cohort 2022 ·Therapeutic Advances in Neurological Disorders ·(unknown), Carsten Saft, Simon Faissner, Gisa Ellrichmann	3
5	Germany-wide evaluation of residency in neurological intensive care medicine 2022 ·BMC Medical Education ·(unknown), Michaela Zupanic, Gisa Ellrichmann, (unknown)	2
6	Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany 2020 ·Clinical Neurology and Neurosurgery ·Sebastian Rauer, Muna‐Miriam Hoshi, Refik Pul, Mathias Wahl, Matthias Schwab, Judith Haas, Gisa Ellrichmann, Markus Krumbholz, Björn Tackenberg, Kai‐Uwe Saum, (unknown), Jost Leemhuis, (unknown), Orhan Aktaş	5
7	Successful Treatment of Severe Digitoxin Intoxication with CytoSorb® Hemoadsorption 2020 ·Blood Purification ·(unknown), Daniel R. Quast, (unknown), (unknown), Gisa Ellrichmann	10
8	Novel variants in a patient with late-onset hyperprolinemia type II: diagnostic key for status epilepticus and lactic acidosis 2019 ·BMC Neurology ·Jeremias Motte, Anna Lena Fisse, Thomas Grüter, Ruth Schneider, Thomas Breuer, Thomas Lücke, Stefan Krueger, Huu Phuc Nguyen, Ralf Gold, Ilya Ayzenberg, Gisa Ellrichmann	8
9	Inhibition of Huntingtin Exon-1 Aggregation by the Molecular Tweezer CLR01 2017 ·Journal of the American Chemical Society ·Tobias Vöpel, Kenny Bravo‐Rodriguez, Sumit Mittal, (unknown), David Gnutt, Abhishek A. Sharma, (unknown), (unknown), Gisa Ellrichmann, Michael Nshanian, Christian Heid, Joseph A. Loo, Frank‐Gerrit Klärner, Thomas Schräder, Gal Bitan, Erich E. Wanker, Simon Ebbinghaus, Elsa Sánchez‐García	45
10	Laquinimod treatment in the R6/2 mouse model 2017 ·Scientific Reports ·Gisa Ellrichmann, (unknown), (unknown), (unknown), Christiane Reick, Liat Hayardeny, Michael R. Hayden, (unknown), Konstanze F. Winklhofer, Carsten Saft, Ralf Gold	42
11	Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions 2017 ·Frontiers in Neurology ·Ruth Schneider, Barbara Bellenberg, Robert Hoepner, Gisa Ellrichmann, Ralf Gold, Carsten Lukas	1
12	Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML) 2017 ·PLoS ONE ·Ruth Schneider, Barbara Bellenberg, Robert Hoepner, (unknown), Gisa Ellrichmann, Aiden Haghikia, Ralf Gold, Carsten Lukas	3
13	Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis 2016 ·Journal of the Neurological Sciences ·Jan Thöne, Ingo Kleiter, Anna Stahl‐Pehe, Gisa Ellrichmann, Ralf Gold, Kerstin Hellwig	7
14	Echogenicity of basal ganglia structures in different Huntington’s disease phenotypes 2014 ·Journal of Neural Transmission ·Carsten Saft, Rainer Hoffmann, Katrin Straßburger-Krogias, Thomas Lücke, Saskia H. Meves, Gisa Ellrichmann, Christos Krogias	6
15	Diagnostic Value of the Impairment of Olfaction in Parkinson's Disease 2013 ·PLoS ONE ·Swaantje Casjens, (unknown), Dirk Woitalla, Gisa Ellrichmann, Michael Turewicz, Christoph Stephan, Martin Eisenacher, Caroline May, Helmut E. Meyer, Thomas Brüning, Beate Pesch	42
16	Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation 2012 ·Journal of Neuroinflammation ·Gisa Ellrichmann, Jan Thöne, De-Hyung Lee, R. Rupec, Ralf Gold, Ralf A. Linker	44
17	Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis 2012 ·International Immunopharmacology ·Jan Thöne, Gisa Ellrichmann, Pedro M. Faustmann, Ralf Gold, Aiden Haghikia	11
18	Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor 2011 ·American Journal Of Pathology ·Jan Thöne, Gisa Ellrichmann, Silvia Seubert, (unknown), (unknown), Rebecca Conrad, Liat Hayardeny, Gıancarlo Comı, Stefan Wiese, Ralf A. Linker, Ralf Gold	115
19	Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system 2009 ·Proceedings of the National Academy of Sciences ·Johannes Stegbauer, De-Hyung Lee, Silvia Seubert, Gisa Ellrichmann, Arndt Manzel, Heda Kvakan, Dominik N. Müller, Stefanie Gaupp, Lars Christian Rump, Ralf Gold, Ralf A. Linker	156
20	Dyskinesien bei Morbus Parkinson - Klinik, Ätiologie, Therapie 2007 ·Fortschritte der Neurologie · Psychiatrie ·Gisa Ellrichmann, Hermann Russ, Tobias Müller	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact